Clinical Trial

Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding

Study acronym: FIERCE
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Anemia is a frequent complication of gastrointestinal bleeding, affecting 61% of the patients. Currently, anemia caused by gastrointestinal bleeding can be treated with iron supplementation. However, the dose and route of the administration are still a question. The FIERCE clinical trial aims to compare the effect of intravenous iron supplementation and oral iron replacement on mortality, unplanned emergency visits, and hospital readmissions in multimorbid patients with acute nonvariceal gastrointestinal bleeding.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-09-28; most recent amendment 2025-03-25.
Trial Details
NCT Number NCT05060731
Lead Sponsor University of Pecs
Conditions GastroIntestinal Bleeding, Anemia
Enrollment 570 participants
Start Date 2025-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-30